FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886019703> ?p ?o ?g. }

• W2886019703 endingPage "e021064" @default.
• W2886019703 startingPage "e021064" @default.
• W2886019703 abstract "Introduction The introduction of targeted therapies for cancer has contributed to dramatic improvements in patient survival. Nevertheless, several targeted therapies have been associated with ‘off-target’ adverse effects, based on varying levels of evidence. To date, this evidence has not been systematically synthesised. We will synthesise published systematic review evidence of cardiovascular toxicity associated with targeted cancer therapies. Methods and analysis We will include systematic reviews of randomised controlled trials and observational studies that report on cardiovascular outcomes for individual agents. We will identify systematic reviews by applying predeveloped, standardised search strategies within Embase, Medline and Cochrane Central. Two independent reviewers will identify reviews published up to 31 December 2016 using predefined eligibility criteria. They will resolve ambiguous cases through consensus, arbitrated by a third reviewer if required. The reviewers will extract and report data according to methodological guidelines for overviews provided by the Cochrane Collaboration, Joanna Briggs Institute and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. They will assess the quality of included reviews by applying the Assessment of Multiple Systematic Reviews tool. They will judge the quality of evidence in included reviews based on their assessment of bias and incorporation into the interpretation of findings. In synthesising the evidence, we will classify agents based on systematic review evidence of toxicity (sufficient, probable, possible or indeterminate) for specific cardiovascular outcomes (congestive heart failure, myocardial infarction, ischaemic heart disease, left ventricular ejection fraction decline, cerebrovascular disease, pulmonary embolism, thrombosis and hypertension). This will provide clinicians and patients with an accessible synthesis based on robust methodology. Ethics and dissemination Ethics approval is not required for overviews. We will conduct the study in collaboration with consumer representatives. We will submit results for peer-review publication, and disseminate them through established clinical and consumer networks. PROSPERO registration number CRD42017080014." @default.
• W2886019703 created "2018-08-22" @default.
• W2886019703 creator A5000938224 @default.
• W2886019703 creator A5002731736 @default.
• W2886019703 creator A5014788047 @default.
• W2886019703 creator A5033182898 @default.
• W2886019703 creator A5035525899 @default.
• W2886019703 creator A5041526616 @default.
• W2886019703 creator A5070179711 @default.
• W2886019703 creator A5075704884 @default.
• W2886019703 date "2018-06-01" @default.
• W2886019703 modified "2023-09-26" @default.
• W2886019703 title "Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews" @default.
• W2886019703 cites W1969682776 @default.
• W2886019703 cites W1978896294 @default.
• W2886019703 cites W2028758832 @default.
• W2886019703 cites W2030654240 @default.
• W2886019703 cites W2073644162 @default.
• W2886019703 cites W2097502993 @default.
• W2886019703 cites W2119790985 @default.
• W2886019703 cites W2131602018 @default.
• W2886019703 cites W2156098321 @default.
• W2886019703 cites W2163661402 @default.
• W2886019703 cites W2169205464 @default.
• W2886019703 cites W2201776847 @default.
• W2886019703 cites W2328437427 @default.
• W2886019703 cites W2364450135 @default.
• W2886019703 cites W2520714999 @default.
• W2886019703 cites W2529592327 @default.
• W2886019703 cites W2530366440 @default.
• W2886019703 cites W2571325344 @default.
• W2886019703 cites W2589903002 @default.
• W2886019703 cites W2602088386 @default.
• W2886019703 cites W2738509363 @default.
• W2886019703 cites W2991792334 @default.
• W2886019703 cites W4211264672 @default.
• W2886019703 doi "https://doi.org/10.1136/bmjopen-2017-021064" @default.
• W2886019703 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6042572" @default.
• W2886019703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29950466" @default.
• W2886019703 hasPublicationYear "2018" @default.
• W2886019703 type Work @default.
• W2886019703 sameAs 2886019703 @default.
• W2886019703 citedByCount "3" @default.
• W2886019703 countsByYear W28860197032020 @default.
• W2886019703 countsByYear W28860197032023 @default.
• W2886019703 crossrefType "journal-article" @default.
• W2886019703 hasAuthorship W2886019703A5000938224 @default.
• W2886019703 hasAuthorship W2886019703A5002731736 @default.
• W2886019703 hasAuthorship W2886019703A5014788047 @default.
• W2886019703 hasAuthorship W2886019703A5033182898 @default.
• W2886019703 hasAuthorship W2886019703A5035525899 @default.
• W2886019703 hasAuthorship W2886019703A5041526616 @default.
• W2886019703 hasAuthorship W2886019703A5070179711 @default.
• W2886019703 hasAuthorship W2886019703A5075704884 @default.
• W2886019703 hasBestOaLocation W28860197031 @default.
• W2886019703 hasConcept C126322002 @default.
• W2886019703 hasConcept C142724271 @default.
• W2886019703 hasConcept C17744445 @default.
• W2886019703 hasConcept C177713679 @default.
• W2886019703 hasConcept C189708586 @default.
• W2886019703 hasConcept C199539241 @default.
• W2886019703 hasConcept C204787440 @default.
• W2886019703 hasConcept C23131810 @default.
• W2886019703 hasConcept C2779473830 @default.
• W2886019703 hasConcept C2780385302 @default.
• W2886019703 hasConcept C535046627 @default.
• W2886019703 hasConcept C71924100 @default.
• W2886019703 hasConceptScore W2886019703C126322002 @default.
• W2886019703 hasConceptScore W2886019703C142724271 @default.
• W2886019703 hasConceptScore W2886019703C17744445 @default.
• W2886019703 hasConceptScore W2886019703C177713679 @default.
• W2886019703 hasConceptScore W2886019703C189708586 @default.
• W2886019703 hasConceptScore W2886019703C199539241 @default.
• W2886019703 hasConceptScore W2886019703C204787440 @default.
• W2886019703 hasConceptScore W2886019703C23131810 @default.
• W2886019703 hasConceptScore W2886019703C2779473830 @default.
• W2886019703 hasConceptScore W2886019703C2780385302 @default.
• W2886019703 hasConceptScore W2886019703C535046627 @default.
• W2886019703 hasConceptScore W2886019703C71924100 @default.
• W2886019703 hasFunder F4320334705 @default.
• W2886019703 hasIssue "6" @default.
• W2886019703 hasLocation W28860197031 @default.
• W2886019703 hasLocation W28860197032 @default.
• W2886019703 hasLocation W28860197033 @default.
• W2886019703 hasLocation W28860197034 @default.
• W2886019703 hasOpenAccess W2886019703 @default.
• W2886019703 hasPrimaryLocation W28860197031 @default.
• W2886019703 hasRelatedWork W1931845227 @default.
• W2886019703 hasRelatedWork W2026515549 @default.
• W2886019703 hasRelatedWork W2040032687 @default.
• W2886019703 hasRelatedWork W2379088263 @default.
• W2886019703 hasRelatedWork W2608616923 @default.
• W2886019703 hasRelatedWork W2615364657 @default.
• W2886019703 hasRelatedWork W2901881702 @default.
• W2886019703 hasRelatedWork W2915086063 @default.
• W2886019703 hasRelatedWork W2949480871 @default.
• W2886019703 hasRelatedWork W4284973126 @default.
• W2886019703 hasVolume "8" @default.

• next